Generated by GPT-5-mini| Grubbs catalyst | |
|---|---|
| Name | Grubbs catalyst |
| Other names | catalysts of the Grubbs type |
| Chemical formula | varies |
| Molar mass | varies |
Grubbs catalyst
The Grubbs catalyst is a family of organoruthenium complexes used for olefin metathesis, developed for applications ranging from laboratory synthesis to industrial BASF-scale processes. It enabled transformative advances recognized by the Nobel Prize in Chemistry and has been applied in contexts including natural product synthesis, polymer science, and pharmaceutical manufacturing. Invented and refined through academic and industrial collaborations, the catalysts bridge research at institutions such as California Institute of Technology, DuPont, Eli Lilly and Company, and Stanford University.
Grubbs catalysts are ruthenium-based complexes enabling catalytic olefin metathesis transformations such as ring-closing metathesis, cross metathesis, and ring-opening metathesis polymerization, with widespread impact across Harvard University-trained synthetic chemists, Pfizer researchers, and materials scientists at Dow Chemical Company. Their development catalyzed progress in total syntheses by groups at Scripps Research Institute, University of California, Berkeley, and ETH Zurich, influencing protocols adopted by the American Chemical Society and taught in courses at Massachusetts Institute of Technology.
Early metathesis research traces to work at DuPont and the Fritz Haber Institute; the key Grubbs series emerged from studies at California Institute of Technology led by Robert H. Grubbs and collaborators. Subsequent industrial partnerships with Merck and BASF scaled applications for commodity and fine chemicals, while recognition culminated in the Nobel Prize in Chemistry awarded for metathesis methodology. Parallel lines of inquiry occurred at Stanford University and University of Chicago, and commercialization involved spin-offs and licensing agreements with firms such as Aldrich Chemical Company and Johnson & Johnson.
Typical Grubbs catalysts are ruthenium complexes bearing phosphine or N-heterocyclic carbene ligands; notable generations include first-, second-, and Hoveyda–Grubbs variants developed through collaborations involving researchers at California Institute of Technology and Université Louis Pasteur. First-generation complexes often feature tricyclohexylphosphine ligands similar to reagents used by teams at University of Bristol and University of Cambridge, while second-generation variants incorporate N-heterocyclic carbenes inspired by work from Guy Bertrand and others. The Hoveyda–Grubbs family links to innovations at Imperial College London and the National Institutes of Health through ligand design adopted by commercial suppliers such as Sigma-Aldrich.
The catalytic cycle proceeds via formation of a metallacyclobutane intermediate and proceeds through reversible [2+2] cycloaddition and cycloreversion steps, concepts advanced by theoreticians at Princeton University and experimentalists at University of California, Los Angeles. Mechanistic elucidation benefited from spectroscopic studies at Max Planck Institute laboratories and computational work by groups at ETH Zurich and University of Oxford, integrating data produced using instrumentation at Argonne National Laboratory and Lawrence Berkeley National Laboratory. Key steps link to organometallic paradigms championed by figures associated with John Hopkins University and Yale University.
Grubbs catalysts have been applied in total syntheses by teams at Scripps Research Institute and Columbia University, polymer production projects at Dow Chemical Company and DuPont, and drug development pipelines at Pfizer and Roche. Industrial-scale olefin metathesis influenced materials used by BASF and Shell, and academic collaborations with University of Illinois Urbana-Champaign and Northwestern University advanced macromolecular design. The technology figures in award-winning syntheses acknowledged by societies such as the Royal Society of Chemistry and in patents filed by Eli Lilly and Company and Merck & Co..
Preparation of Grubbs catalysts originated in academic laboratories at California Institute of Technology and was adapted for scale-up in pilot plants at DuPont and BASF. Protocols employ air-sensitive techniques refined in instructor-led labs at Massachusetts Institute of Technology and University of Cambridge, and analytic validation is commonly performed with instruments at National Institute of Standards and Technology and university core facilities such as those at University of California, San Diego. Commercial production and distribution involve chemical suppliers like Sigma-Aldrich and TCI Chemicals.
Reactivity profiles were characterized by research groups at ETH Zurich and University of California, Berkeley, while stability and storage considerations have been addressed in industrial settings at BASF and Dow Chemical Company. Safety and handling guidelines align with standards promulgated by agencies including the Occupational Safety and Health Administration and testing in GLP facilities connected to National Institutes of Health-funded cores. Environmental impact assessments involve collaborations with laboratories at Oak Ridge National Laboratory and university environmental chemistry groups at University of Michigan.
Category:Catalysts Category:Organoruthenium compounds Category:Organometallic chemistry